Disruption of Npr1 gene differentially regulates the juxtaglomerular and distal tubular renin levels in null mutant mice

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 4, Issue 3, 2012, Pages 128-139

  Prieto, Minolfa C ^a   Das, Subhankar ^a   Somanna, Naveen K ^a   Harrison Bernard, Lisa M ^b   Navar, L Gabriel ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial natriuretic peptide receptor a; Distal tubular and juxtaglomerular renin; Gene disrupted mice; Hypertension; Immunohistochemistry

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIURETIC AGENT; NATRIURETIC PEPTIDE RECEPTOR B; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUXTAGLOMERULAR APPARATUS; KIDNEY DISTAL TUBULE; MOUSE; MOUSE MUTANT; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

EID: 84867041452     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 2005; 26: 901-932.
2. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665-699.
3. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science 1985; 230: 767-770.
4. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
5. de Bold AJ, Borenstein HB, Veress AT, Sonnen-berg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
6. Meyer M, Forsmann M. Renal actions of atrial natriuretic peptide. Totawa NJ: Humana Press 1997; p: 147-170.
7. Zhao D, Pandey KN, Navar LG. ANP-mediated inhibition of distal nephron fractional sodium reabsorption in wild-type and mice overexpressing natriuretic peptide receptor. Am J Physiol Renal Physiol 2010; 298: F103-108.
8. Pandey KN. Emerging Roles of Natriuretic Pep-tides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation. J Am Soc Hypertens 2008; 2: 210-226.
9. Shi SJ, Nguyen HT, Sharma GD, Navar LG, Pandey KN. Genetic disruption of atrial natri-uretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol 2001; 281: F665-673.
10. Dubois SK, Kishimoto I, Lillis TO, Garbers DL. A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function. Proc Natl Acad Sci USA 2000; 97: 4369-4373.
11. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev 1994; 15: 135-162.
12. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 1992; 71: 1-4.
13. Pandey KN, Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 1990; 265: 12342-12348.
14. Pandey KN. The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms. FEBS J 2011; 278: 1792-1807.
15. Pandey KN, Oliver PM, Maeda N, Smithies O. Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 1999; 140: 5112-5119.
16. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997; 94: 14730-14735.
17. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 2002; 99: 7142-7147.
18. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995; 267: 679-681.
19. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, Beuve A. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 1995; 378: 65-68.
20. Vellaichamy E, Khurana ML, Fink J, Pandey KN. Involvement of the NF-kappa B/matrix metallo-proteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J Biol Chem 2005; 280: 19230-19242.
21. Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 2003; 285: F694-702.
22. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, Smithies O. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 1998; 95: 2547-2551.
23. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, Maeda N. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 2001; 107: 975-984.
24. Vellaichamy E, Zhao D, Somanna N, Pandey KN. Genetic disruption of guanylyl cyclase/ natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol Genom-ics 2007; 31: 193-202.
25. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocri-nol 2007; 38: 245-257.
26. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Ina-gami T, Ward K, Terreros DA, Lalouel JM. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999; 34: 1265-1274.
27. Majid DS, Navar LG. Blockade of distal nephron sodium transport attenuates pressure natriure-sis in dogs. Hypertension 1994; 23: 1040-1045.
28. Prieto M, Dipp S, Meleg-Smith S, El-Dahr SS. Ureteric bud derivatives express angiotensino-gen and AT1 receptors. Physiol Genomics 2001; 6: 29-37.
29. Pandey KN, Inagami T. Regulation of renin an-giotensins by gonadotropic hormones in cultured murine Leydig tumor cells. Release of angiotensin but not renin. J Biol Chem 1986; 261: 3934-3938.
30. Henrich WL, McAllister EA, Eskue A, Miller T, Moe OW. Renin regulation in cultured proximal tubular cells. Hypertension 1996; 27: 1337-1340.
31. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, Thomas J, Xiao S, Ishigami T, Herrmann T, Terreros DA, Ward K, Lalouel JM. Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension 2002; 39: 1007-1014.
32. Tank JE, Henrich WL, Moe OW. Regulation of glomerular and proximal tubule renin mRNA by chronic changes in dietary NaCl. Am J Physiol 1997; 273: F892-898.
33. Taugner R, Hackenthal E, Inagami T, Nobiling R, Poulsen K. Vascular and tubular renin in the kidneys of mice. Histochemistry 1982; 75: 473-484.
34. Taugner R, Mannek E, Nobiling R, Buhrle CP, Hackenthal E, Ganten D, Inagami T, Schröder H. Coexistence of renin and angiotensin II in epitheloid cell secretory granules of rat kidney. Histochemistry 1984; 81: 39-45.
35. Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: Implications for the pathogenesis of tubulointersti-tial fibrosis. Am J Pathol 1999; 155: 429-440.
36. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE, Schor N. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 1997; 272: F405-409.
37. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 2003; 42: 195-199.
38. Cervenka L, Mitchell KD, Navar LG. Renal function in mice effects of volume expansion and angiotensin II. J Am Soc Nephro 1999; 10: 2631-2636.
39. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004; 44: 223-229.
40. Wang CT, Navar LG, Mitchell KD. Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 353-360.
41. Peti-Peterdi J, Warnock DG, Bell PD. Angio-tensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002; 13: 1131-1135.
42. Prieto-Carrasquero MC, Kobori H, Ozawa Y, Gutierrez A, Seth D, Navar LG. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 2005; 289: F632-637.
43. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszódi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fässler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. Embo J 1998; 17: 3045-3051.
44. Kaupp UB, Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev 2002; 82: 769-824.
45. Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS, Jimmo SL. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol 2003; 64: 533-546.
46. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 2003; 93: 280-291.
47. Schlossmann J, Feil R, Hofmann F. Insights into cGMP signalling derived from cGMP kinase knockout mice. Front Biosci 2005; 10: 1279-1289.
48. Melo LG, Veress AT, Ackermann U, Steinhelper ME, Pang SC, Tse Y, Sonnenberg H. Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc Res 1999; 43: 437-444.
49. Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H. Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. Am J Physiol 1998; 274: R255-261.
50. Sayago CM, Beierwaltes WH. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1146-1151.
51. Chiu YJ, Reid IA. Effect of sildenafil on renin secretion in human subjects. Exp Biol Med (Maywood) 2002; 227: 620-625.
52. Friis UG, Jensen BL, Sethi S, Andreasen D, Han-sen PB, Skott O. Control of renin secretion from rat juxtaglomerular cells by cAMP-specific phos-phodiesterases. Circ Res 2002; 90: 996-1003.
53. Persson PB. Renin: origin, secretion and synthesis. J Physiol 2003; 552: 667-671.
54. Kurtz A, Wagner C. Cellular control of renin secretion. J Exp Biol 1999; 202: 219-225.
55. Prieto-Carrasquero MC, Botros FT, Pagan J, Kobori H, Seth DM, Casarini DE, Navar LG. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 2008; 51: 1590-1596.
56. Casarini DE, Plavinik FL, Zanella MT, Marson O, Krieger JE, Hirata IY, Stella RC. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol 2001; 33: 75-85.
57. Redublo Quinto BM, Camargo de Andrade MC, Ronchi FA, Santos EL, Alves Correa SA, Shimuta SI, Pesquero JB, Mortara RA, Casarini DE. Expression of angiotensin I-converting enzymes and bradykinin B2 receptors in mouse inner medullary-collecting duct cells. Int Immuno-pharmacol 2008; 8: 254-260.